Enhancing CAR T‐cell therapy manufacturing efficiency through semi‐automated bioprocessing
Abstract Objectives Chimeric antigen receptor (CAR) T‐cell therapies have revolutionised the treatment of blood‐based malignancies. The use of manual CAR T‐cell manufacturing methods is one of the challenges that contributes to these delays. As CAR T therapy emerges as a potential first‐ or second‐l...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Clinical & Translational Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cti2.70025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|